Who
Melina E. Higgins
Director
Company insider
Files Form 4 as: Director, Genworth Financial; Director, Viatris; Other, Virgin Orbit Holdings; Director, Mylan II B.V; Director, Mylan.
In numbers
- Trades disclosed
- 151
- Buys
- 6
- Sells
- 1
- Bought
- $3.6M
- Sold
- $610K
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 28 May 2013
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | GNW Genworth FinancialInsurance | SEC FORM 4 Code A | $285K31,547 at $9.03 | filing |
| 20 May 2026filed 21 May 2026 | GNW Genworth FinancialInsurance | SEC FORM 4 Code A | $285K31,547 at $9.03 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —23,660 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —1,175 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —23,660 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —23,660 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,174.49 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,890 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,174.492 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —15,890 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —23,660 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —1,175 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | GNW Genworth FinancialInsurance | SEC FORM 4 Code A | $285K40,904.2 at $6.97 | filing |
| 6 Mar 2025filed 10 Mar 2025 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —23,660 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —18,204 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —772.84 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —18,204 at $0.00 | filing |
| 4 Mar 2025filed 5 Mar 2025 | VTRS ViatrisPharmaceuticals | SEC FORM 4 Code M | —773 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | GNW Genworth FinancialInsurance | SEC FORM 4 Code A | $270K41,935.23 at $6.44 | filing |
| 4 Mar 2024filed 5 Mar 2024 | VTRS Viatrisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —18,204 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.